NBRV - Nabriva Therapeutics EPS beats by $0.01 beats on revenue November, 09 2021 04:02 PM Nabriva Therapeutics plc Nabriva Therapeutics (NASDAQ:NBRV): Q3 GAAP EPS of -$0.21 beats by $0.01. Revenue of $8.9M (+589.9% Y/Y) beats by $0.01M. Press Release For further details see: Nabriva Therapeutics EPS beats by $0.01, beats on revenue